Latest News & Features
Americas
A panel of the US Court of Appeals for the Federal Circuit has considered for a second time the $235 million award to GlaxoSmithKline after Teva Pharmaceuticals was found to have infringed its Coreg heart drug. 25 February 2021
Big Pharma
Innovation by medical and pharma sectors has increased over the past year in the wake of the pandemic, a new report by IP services company Clarivate has confirmed. 23 February 2021
Big Pharma
Bayer Healthcare is suing medical devices manufacturer Ecomed Solutions over allegedly patent-infringing syringes. 23 February 2021
Big Pharma
AbbVie and its Korean partner Medytox have settled a trade secret dispute with competitor Evolus over the sale of a rival botox competitor drug Jeuveau. 23 February 2021
Americas
The US Court of Appeals for the Federal Circuit has cancelled claims of a Melanoscan patent covering methods of detecting skin cancer. 22 February 2021
Big Pharma
Irish pharmaceutical company Amarin has petitioned the Supreme Court to revive its patents on its heart medication Vascepa. 18 February 2021
Biotechnology
The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews. 18 February 2021
Genetics
ERS Genomics has agreed to license CRISPR-Cas9 technology to a Barcelona-based start-up which uses a zebrafish-based research model. 18 February 2021
Big Pharma
Gilead Sciences and Bristol-Myers Squibb have said that a suit alleging they were involved in a long-running scheme to block generic competition and keep HIV medication prices artificially high is “legally defective”. 16 February 2021
Americas
The US Court of Appeals for the Federal Circuit has invalidated two Amgen antibody patents, finding that their functional claims were too broad. 16 February 2021